Free Trial
NYSEARCA:LABU

Direxion Daily S&P Biotech Bull 3x Shares (LABU) Price, Holdings, & News

Direxion Daily S&P Biotech Bull 3x Shares logo
$107.22 +1.22 (+1.15%)
(As of 02:35 PM ET)

About Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU)

Key Stats

Today's Range
$101.69
$110.73
50-Day Range
$99.35
$146.96
52-Week Range
$66.80
$176.99
Volume
1.52 million shs
Average Volume
1.95 million shs
Market Capitalization
$1.12 billion
Assets Under Management
$870.96 million
Dividend Yield
0.59%
Net Expense Ratio
0.96%
Aggregate Rating
Moderate Buy

ETF Overview

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Direxion Daily S&P Biotech Bull 3x Shares Expenses

TypeLABUHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.57%0.55%0.51%0.52%
Other Expenses0.21%0.30%0.49%0.57%0.53%
Total Expense0.96%0.70%0.71%0.73%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.67%-0.57%
Net Expense0.96%0.61%0.61%0.58%0.59%
Receive LABU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

LABU ETF News Headlines

ULTY: ~74% Trailing Yield, But Look Out Below
2024 Election Year Stocks: Uncover Hidden Gems!
In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.
The 3 Best Leveraged ETFs for April 2024
See More Headlines

LABU ETF - Frequently Asked Questions

Direxion Daily S&P Biotech Bull 3x Shares' stock was trading at $121.97 at the beginning of 2024. Since then, LABU stock has decreased by 15.2% and is now trading at $103.38.
View the best growth stocks for 2024 here
.

Direxion Daily S&P Biotech Bull 3x Shares shares reverse split on the morning of Monday, December 4th 2023. The 1-20 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Direxion Daily S&P Biotech Bull 3x Shares' top institutional shareholders include Jane Street Group LLC, TB Alternative Assets Ltd. (0.40%), Wolverine Trading LLC and Traynor Capital Management Inc. (0.10%).

Shares of LABU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bull 3x Shares investors own include Micron Technology (MU), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AT&T (T), Direxion Daily Semiconductors Bull 3x Shares (SOXL) and Advanced Micro Devices (AMD).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily S&P Biotech Bull 3x Shares
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:LABU
Inception Date
5/28/2015
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
173

Fund Statistics

Assets Under Management
$823.77 million
Average Daily Volume
$1.18 million
Discount/Premium
0.09%
Leveraged
3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
4,551
Put Options
1,728
Call Options
2,823
Short Interest
751,800 shs

Miscellaneous

Beta
3.31
Creation Unit
50,000
Creation Fee
$250.00
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 10 LABU Holdings

  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 44.79%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 36.60%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 36.47%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 36.23%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 34.94%
  • DREYFUS GOVT CASH MAN INS
    Holding Weight: 30.28%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 28.82%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: 16.35%
  • GOLDMAN FINL SQ TRSRY INST 506
    Holding Weight: 7.96%
  • DREYFUS TRSRY SECURITIES CASH MGMT
    Holding Weight: 3.57%

LABU Sector Exposure

LABU Industry Exposure


This page (NYSEARCA:LABU) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners